Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7

Signal Transduct Target Ther. 2021 Feb 22;6(1):84. doi: 10.1038/s41392-021-00497-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Inflammation / drug therapy
  • Macrophages
  • Monocytes
  • SARS-CoV-2*